Bio-Rad Laboratories, Inc. BIO.B Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s stock issuance proceeds?
- Bio-Rad Laboratories, Inc. (BIO.B) reported stock issuance proceeds of $3.4M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s stock issuance proceeds changed year-over-year?
- Bio-Rad Laboratories, Inc.'s stock issuance proceeds decreased by 20.9% year-over-year, from $4.3M to $3.4M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s stock issuance proceeds has grown at a -8.3% compound annual growth rate (CAGR), from -$22.32M to $15.8M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.